Cargando…

SARS-CoV-2 and miRNA-like inhibition power

(1) Background: RNA viruses and especially coronaviruses could act inside host cells not only by building their own proteins, but also by perturbing the cell metabolism. We show the possibility of miRNA-like inhibitions by the SARS-CoV-2 concerning for example the hemoglobin and type I interferons s...

Descripción completa

Detalles Bibliográficos
Autores principales: Demongeot, Jacques, Seligmann, Hervé
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471724/
https://www.ncbi.nlm.nih.gov/pubmed/33254550
http://dx.doi.org/10.1016/j.mehy.2020.110245
_version_ 1783578828592906240
author Demongeot, Jacques
Seligmann, Hervé
author_facet Demongeot, Jacques
Seligmann, Hervé
author_sort Demongeot, Jacques
collection PubMed
description (1) Background: RNA viruses and especially coronaviruses could act inside host cells not only by building their own proteins, but also by perturbing the cell metabolism. We show the possibility of miRNA-like inhibitions by the SARS-CoV-2 concerning for example the hemoglobin and type I interferons syntheses, hence highly perturbing oxygen distribution in vital organs and immune response as described by clinicians; (2) Hypothesis: We hypothesize that short RNA sequences (about 20 nucleotides in length) from the SARS-CoV-2 virus genome can inhibit the translation of human proteins involved in oxygen metabolism, olfactory perception and immune system. (3) Methods: We compare RNA subsequences of SARS-CoV-2 protein S and RNA-dependent RNA polymerase genes to mRNA sequences of beta-globin and type I interferons; (4) Results: RNA subsequences longer than eight nucleotides from SARS-CoV-2 genome could hybridize subsequences of the mRNA of beta-globin and of type I interferons; (5) Conclusions: Beyond viral protein production, COVID-19 might affect vital processes like host oxygen transport and immune response.
format Online
Article
Text
id pubmed-7471724
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-74717242020-09-04 SARS-CoV-2 and miRNA-like inhibition power Demongeot, Jacques Seligmann, Hervé Med Hypotheses Article (1) Background: RNA viruses and especially coronaviruses could act inside host cells not only by building their own proteins, but also by perturbing the cell metabolism. We show the possibility of miRNA-like inhibitions by the SARS-CoV-2 concerning for example the hemoglobin and type I interferons syntheses, hence highly perturbing oxygen distribution in vital organs and immune response as described by clinicians; (2) Hypothesis: We hypothesize that short RNA sequences (about 20 nucleotides in length) from the SARS-CoV-2 virus genome can inhibit the translation of human proteins involved in oxygen metabolism, olfactory perception and immune system. (3) Methods: We compare RNA subsequences of SARS-CoV-2 protein S and RNA-dependent RNA polymerase genes to mRNA sequences of beta-globin and type I interferons; (4) Results: RNA subsequences longer than eight nucleotides from SARS-CoV-2 genome could hybridize subsequences of the mRNA of beta-globin and of type I interferons; (5) Conclusions: Beyond viral protein production, COVID-19 might affect vital processes like host oxygen transport and immune response. Elsevier Ltd. 2020-11 2020-09-04 /pmc/articles/PMC7471724/ /pubmed/33254550 http://dx.doi.org/10.1016/j.mehy.2020.110245 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Demongeot, Jacques
Seligmann, Hervé
SARS-CoV-2 and miRNA-like inhibition power
title SARS-CoV-2 and miRNA-like inhibition power
title_full SARS-CoV-2 and miRNA-like inhibition power
title_fullStr SARS-CoV-2 and miRNA-like inhibition power
title_full_unstemmed SARS-CoV-2 and miRNA-like inhibition power
title_short SARS-CoV-2 and miRNA-like inhibition power
title_sort sars-cov-2 and mirna-like inhibition power
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471724/
https://www.ncbi.nlm.nih.gov/pubmed/33254550
http://dx.doi.org/10.1016/j.mehy.2020.110245
work_keys_str_mv AT demongeotjacques sarscov2andmirnalikeinhibitionpower
AT seligmannherve sarscov2andmirnalikeinhibitionpower